Clinical Trial Update: STAR-AF:Substrate Versus Trigger Ablation for Reduction of Atrial Fibrillation Trial [NA]

View source ↗

Summary

The STAR-AF trial comparing substrate versus trigger ablation strategies for reducing atrial fibrillation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Snippet

Sponsor: Abbott Medical Devices | Conditions: Atrial Fibrillation | NA | Status: COMPLETED